Fermenta Biotech (BOM:506414) Debt-to-Equity : 0.43 (As of Sep. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Fermenta Biotech Debt-to-Equity?

Fermenta Biotech's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹969 Mil. Fermenta Biotech's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹278 Mil. Fermenta Biotech's Total Stockholders Equity for the quarter that ended in Sep. 2024 was ₹2,901 Mil. Fermenta Biotech's debt to equity for the quarter that ended in Sep. 2024 was 0.43.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Fermenta Biotech's Debt-to-Equity or its related term are showing as below:

BOM:506414' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.23 Med: 0.62 Max: 1.39
Current: 0.43

During the past 13 years, the highest Debt-to-Equity Ratio of Fermenta Biotech was 1.39. The lowest was 0.23. And the median was 0.62.

BOM:506414's Debt-to-Equity is ranked worse than
62.47% of 826 companies
in the Drug Manufacturers industry
Industry Median: 0.27 vs BOM:506414: 0.43

Fermenta Biotech Debt-to-Equity Historical Data

The historical data trend for Fermenta Biotech's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fermenta Biotech Debt-to-Equity Chart

Fermenta Biotech Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Equity

Get a 7-Day Free Trial

0.72

0.64

0.70

0.48

Fermenta Biotech Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Equity	Get a 7-Day Free Trial															0.60	N/A	0.48	N/A	0.43

Competitive Comparison of Fermenta Biotech's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Fermenta Biotech's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fermenta Biotech's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fermenta Biotech's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Fermenta Biotech's Debt-to-Equity falls into.

Fermenta Biotech Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Fermenta Biotech's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(906.93	+	480.748)	/	2888.61
	=	0.48

Fermenta Biotech's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(968.829	+	278.356)	/	2900.933
	=	0.43

Fermenta Biotech (BOM:506414) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Fermenta Biotech Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Fermenta Biotech's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Fermenta Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fermenta Biotech Ltd (BOM:506414) » Definitions » Debt-to-Equity

Traded in Other Exchanges

N/A

Address

Ghodbunder Road, A -1501, Thane One, DIL Complex, Majiwada, Thane (West), Thane, MH, IND, 400610

Website

https://www.fermentabiotech.com

Fermenta Biotech Ltd is engaged in the business of manufacturing and marketing chemicals, bulk drugs, enzymes, pharmaceutical formulations, and environmental solution products and renting and selling properties. It is a manufacturer and supplier of Vitamin D and also supplies Penicillin G Amidase, CAL B Lipase, Polymer Supports, and enzyme technologies. The company operates in two segments that are Property and Bulk Drugs/Chemicals. The majority of the revenue comes from the Bulk Drug/Chemicals segment. Geographically, it caters to both domestic and international markets and generates maximum revenue from the Indian market.

Fermenta Biotech Headlines

No Headlines